Related Experiment Videos
Studies on paracetamol binding to serum proteins
T P Milligan1, H C Morris, P M Hammond
1Department of Clinical Biochemistry, London Hospital Medical College, UK.
Annals of Clinical Biochemistry
|September 1, 1994
Summary
Paracetamol (acetaminophen) shows limited binding to plasma proteins, averaging 24.1%. This binding increases slightly with higher albumin levels but is not significantly affected by drug concentration or kidney function in overdose cases.
Area of Science:
- Pharmacology
- Clinical Chemistry
- Analytical Chemistry
Background:
- Limited data exists on paracetamol (acetaminophen) plasma protein binding.
- Protein binding can affect drug quantification and interpretation of clinical data.
- Understanding binding is crucial for accurate risk assessment and antidote efficacy.
Purpose of the Study:
- To investigate the extent of paracetamol binding to plasma proteins.
- To determine if binding is influenced by drug concentration, uraemia, or albumin levels.
Main Methods:
- Utilized an ultrafiltration technique to assess paracetamol binding.
- Analyzed plasma samples from overdose patients and spiked uraemic samples.
- Examined binding in pure serum albumin solutions.
Main Results:
- Mean paracetamol binding was 24.1% (SD=7.0) in overdose and uraemic samples.
- No significant correlation was found between binding and paracetamol levels or uraemia severity.
- A small but significant positive correlation between paracetamol binding and serum albumin concentration was observed.
Conclusions:
- Paracetamol exhibits low plasma protein binding.
- Albumin concentration is a key factor influencing paracetamol binding.
- Binding does not appear to be a major confounder in routine therapeutic drug monitoring or risk assessment for paracetamol overdose.